Article Sidebar
Main Article Content
Abstract
Ketoprofen is included in the Class II of Biopharmaceutical Classification System (BCS) which has low solubility. Low solubility will affect the dissolution rate and the dissolved concentration, so the absorption and bioavailability are low as well. Several studies have been conducted to improve the solubility and the dissolution of drugs from these group, such as by solid dispersion system. This study aims to determine the effect of polyvinyl alcohol (PVA) on the dissolved concentration of ketoprofen in solid dispersion and in physical mixture, and to decidethe optimum formula.Solid dispersion and physical mixture of ketoprofen - PVA were formulated with the ratio of 1:1, 1:2 and 1:4, and then compared with the standard ketoprofen. Evaluation of solid dispersion was performed by the intervention test of PVA as a matrix on the maximum wavelength of standard ketoprofen using a UV-Vis spectrophotometer and the dissolution test in artificial gastric fluid media without pepsin using a basket stirrer at pH ± 1,2, the temperature of 37 ± 0.5ºC, and device speed of 50 rpm. The sample was collected at 10, 20, 30, 45, and 60 minutes. The amount of dissolved ketoprofen was determined by a UV-Vis spectrophotometer at a wavelength of 260 nm. The results showed that there was no shifting on maximum wavelength point in both solid dispersions and physical mixtures. The dissolved ketoprofen concentration that was represented in solid dispersion was greater than in physical mixture and standard ketoprofen. The highest dissolved ketoprofen concentration was indicated in solid dispersion formula with the ratio of 1:1.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Alatas, F., Nurono S. & Asyarie, S. (2006). Pengaruh konsentrasi PEG 4000 terhadap laju disolusi ketoprofen dalam sistem dispersi padat ketoprofen – PEG 4000. Majalah Farmasi Indonesia, 17(2), 57–62.
Anonim. (1979). Farmakope Indonesia (edisi III). Jakarta, Departemen Kesehatan Republik Indonesia.
Anonim. (1995). Farmakope Indonesia (edisi IV). Jakarta, Departemen Kesehatan Republik Indonesia.
Arias, M.J., Ginos, J.M., Moyano, J.R., Porez-Martinez, J.I., Rabasco, A.M. (1995). Influence of the preparation method of solid dispersions on their dissolution rate: study of triamterene-D-mannitol system. International Journal of Pharmaceutics, 123, 25–31.
Chaudhari, P.D. (2006). Current trends in solid dispersions techniques. Journal of Pharmainfo, 1.
Drooge, D.J. (2006). Production, stability, and dissolution of solid dispersions to improve the bioavailability of class II lipophilic drugs. Dissertation of Science, 13, 15 – 18 , 32 – 33.
Gennaro, Alfonso R., et al. (1990). Remington’s Pharmaceutical Science (18thed.). Pennsylvania, Mack Publishing Company.
Janssens, S., de Armas HN., Remon, JP., & Van den Mootera, G. (2007). The use of a new hydrophilic polymer, Kollicoat IR®, in the formulation of solid dispersions of Itraconazole, European Journal of Pharmaceutical Sciences, 30, 288 – 294.
Leuner, C. & Dressman, J. (2000). Improving drug solubility for oral delivery using solid dispersion. European Journal Pharmaceutics and Biopharmaceutics, 50, 47 – 60.
Parfitt, K. (1999). Martindale: The Complete Drug Reference (vol.1). London, Pharmaceutical Press.
Saifullah, T.N. (2008). Teknik Peningkatan Disolusi dan Bioavailibilitas. Yogyakarta, Universitas Gajah Mada.
Serajuddin, ATM. (1999). Solid dispersion of poorly water-soluble drugs: Early Promises, Subsequent Problems and Recent Breakthroughs. Journal of Pharmaceutical Science, 351.
Shargel, L., Yu A. (2005). Biofarmasetika dan Farmakokinetika Terapan(edisi kedua). Surabaya, Airlangga University Press.
Tan H., Tjay dan Raharja K. (1986). Obat-obat Penting, Khasiat, Penggunaan, dan Efek-efek Sampingnya (edisi IV). Jakarta, Departemen Kesehatan Republik Indonesia.